Functional  ||| S:0 E:11 ||| JJ
electrical  ||| S:11 E:22 ||| JJ
stimulation  ||| S:22 E:34 ||| NN
based  ||| S:34 E:40 ||| VBN
on  ||| S:40 E:43 ||| IN
a  ||| S:43 E:45 ||| DT
working  ||| S:45 E:53 ||| JJ
pattern  ||| S:53 E:61 ||| NN
influences  ||| S:61 E:72 ||| NNS
function  ||| S:72 E:81 ||| VBP
of  ||| S:81 E:84 ||| IN
lower  ||| S:84 E:90 ||| JJR
extremity  ||| S:90 E:100 ||| NN
in  ||| S:100 E:103 ||| IN
subjects  ||| S:103 E:112 ||| NNS
with  ||| S:112 E:117 ||| IN
early  ||| S:117 E:123 ||| JJ
stroke  ||| S:123 E:130 ||| NN
and  ||| S:130 E:134 ||| CC
effects  ||| S:134 E:142 ||| NNS
on  ||| S:142 E:145 ||| IN
diffusion  ||| S:145 E:155 ||| JJ
tensor  ||| S:155 E:162 ||| JJ
imaging ||| S:162 E:169 ||| NN
:  ||| S:169 E:171 ||| :
a  ||| S:171 E:173 ||| DT
randomized  ||| S:173 E:184 ||| JJ
controlled  ||| S:184 E:195 ||| JJ
trial  ||| S:195 E:201 ||| NN
To  ||| S:201 E:204 ||| TO
explore  ||| S:204 E:212 ||| VB
the  ||| S:212 E:216 ||| DT
possible  ||| S:216 E:225 ||| JJ
mechanisms  ||| S:225 E:236 ||| NNS
for  ||| S:236 E:240 ||| IN
improving  ||| S:240 E:250 ||| VBG
lower  ||| S:250 E:256 ||| RBR
extremity  ||| S:256 E:266 ||| JJ
motor  ||| S:266 E:272 ||| NN
function  ||| S:272 E:281 ||| NN
in  ||| S:281 E:284 ||| IN
patients  ||| S:284 E:293 ||| NNS
with  ||| S:293 E:298 ||| IN
early  ||| S:298 E:304 ||| JJ
stroke  ||| S:304 E:311 ||| NN
through  ||| S:311 E:319 ||| IN
combining  ||| S:319 E:329 ||| VBG
magnetic  ||| S:329 E:338 ||| JJ
resonance  ||| S:338 E:348 ||| FW
diffusion  ||| S:348 E:358 ||| FW
tensor  ||| S:358 E:365 ||| FW
imaging  ||| S:365 E:373 ||| FW
( ||| S:373 E:374 ||| -LRB-
DTI ||| S:374 E:377 ||| NNP
)  ||| S:377 E:379 ||| -RRB-
technology  ||| S:379 E:390 ||| NN
and  ||| S:390 E:394 ||| CC
functional  ||| S:394 E:405 ||| JJ
electrical  ||| S:405 E:416 ||| JJ
stimulation  ||| S:416 E:428 ||| NN
( ||| S:428 E:429 ||| -LRB-
FES ||| S:429 E:432 ||| NNP
)  ||| S:432 E:434 ||| -RRB-
based  ||| S:434 E:440 ||| VBN
on  ||| S:440 E:443 ||| IN
human  ||| S:443 E:449 ||| JJ
walking  ||| S:449 E:457 ||| NN
patterns ||| S:457 E:465 ||| NNS
.  ||| S:465 E:467 ||| .
From  ||| S:467 E:472 ||| IN
August  ||| S:472 E:479 ||| NNP
2012  ||| S:479 E:484 ||| CD
to  ||| S:484 E:487 ||| TO
September  ||| S:487 E:497 ||| NNP
2013 ||| S:497 E:501 ||| CD
,  ||| S:501 E:503 ||| ,
a  ||| S:503 E:505 ||| DT
total  ||| S:505 E:511 ||| NN
of  ||| S:511 E:514 ||| IN
48  ||| S:514 E:517 ||| CD
eligible  ||| S:517 E:526 ||| JJ
patients  ||| S:526 E:535 ||| NNS
were  ||| S:535 E:540 ||| VBD
stratified  ||| S:540 E:551 ||| VBN
according  ||| S:551 E:561 ||| VBG
to  ||| S:561 E:564 ||| TO
age ||| S:564 E:567 ||| NN
,  ||| S:567 E:569 ||| ,
gender ||| S:569 E:575 ||| NN
,  ||| S:575 E:577 ||| ,
disease  ||| S:577 E:585 ||| NN
course ||| S:585 E:591 ||| NN
,  ||| S:591 E:593 ||| ,
Brunnstrom  ||| S:593 E:604 ||| NNP
staging  ||| S:604 E:612 ||| NN
and  ||| S:612 E:616 ||| CC
types  ||| S:616 E:622 ||| NNS
of  ||| S:622 E:625 ||| IN
stroke ||| S:625 E:631 ||| NN
.  ||| S:631 E:633 ||| .
And  ||| S:633 E:637 ||| CC
the  ||| S:637 E:641 ||| DT
Minimize  ||| S:641 E:650 ||| JJ
software  ||| S:650 E:659 ||| NN
was  ||| S:659 E:663 ||| VBD
used  ||| S:663 E:668 ||| VBN
to  ||| S:668 E:671 ||| TO
divided  ||| S:671 E:679 ||| VB
them  ||| S:679 E:684 ||| PRP
randomly  ||| S:684 E:693 ||| RB
into  ||| S:693 E:698 ||| IN
four-channel  ||| S:698 E:711 ||| NNP
FES  ||| S:711 E:715 ||| NNP
group  ||| S:715 E:721 ||| NN
( ||| S:721 E:722 ||| -LRB-
n  ||| S:722 E:724 ||| CD
=  ||| S:724 E:726 ||| SYM
18 ||| S:726 E:728 ||| CD
) ||| S:728 E:729 ||| -RRB-
,  ||| S:729 E:731 ||| ,
dual-channel  ||| S:731 E:744 ||| NNP
FES  ||| S:744 E:748 ||| NNP
group  ||| S:748 E:754 ||| NN
( ||| S:754 E:755 ||| -LRB-
n  ||| S:755 E:757 ||| CD
=  ||| S:757 E:759 ||| SYM
15 ||| S:759 E:761 ||| CD
)  ||| S:761 E:763 ||| -RRB-
and  ||| S:763 E:767 ||| CC
comfort  ||| S:767 E:775 ||| NN
stimulation  ||| S:775 E:787 ||| NN
group  ||| S:787 E:793 ||| NN
( ||| S:793 E:794 ||| -LRB-
n  ||| S:794 E:796 ||| CD
=  ||| S:796 E:798 ||| SYM
15 ||| S:798 E:800 ||| CD
) ||| S:800 E:801 ||| -RRB-
.  ||| S:801 E:803 ||| .
For  ||| S:803 E:807 ||| IN
all  ||| S:807 E:811 ||| DT
three  ||| S:811 E:817 ||| CD
groups ||| S:817 E:823 ||| NNS
,  ||| S:823 E:825 ||| ,
general  ||| S:825 E:833 ||| JJ
medication  ||| S:833 E:844 ||| NN
and  ||| S:844 E:848 ||| CC
standard  ||| S:848 E:857 ||| JJ
rehabilitation  ||| S:857 E:872 ||| NN
were  ||| S:872 E:877 ||| VBD
provided ||| S:877 E:885 ||| VBN
.  ||| S:885 E:887 ||| .
Based  ||| S:887 E:893 ||| VBN
on  ||| S:893 E:896 ||| IN
normal  ||| S:896 E:903 ||| JJ
walking  ||| S:903 E:911 ||| NN
pattern  ||| S:911 E:919 ||| NN
design  ||| S:919 E:926 ||| NN
of  ||| S:926 E:929 ||| IN
FES  ||| S:929 E:933 ||| NNP
treatment ||| S:933 E:942 ||| NN
,  ||| S:942 E:944 ||| ,
four-channel  ||| S:944 E:957 ||| NNP
FES  ||| S:957 E:961 ||| NNP
groups  ||| S:961 E:968 ||| NNS
received  ||| S:968 E:977 ||| VBD
the  ||| S:977 E:981 ||| DT
stimulations  ||| S:981 E:994 ||| NN
of  ||| S:994 E:997 ||| IN
quadriceps ||| S:997 E:1007 ||| NN
,  ||| S:1007 E:1009 ||| ,
hamstring ||| S:1009 E:1018 ||| NN
,  ||| S:1018 E:1020 ||| ,
anterior  ||| S:1020 E:1029 ||| JJ
tibialis  ||| S:1029 E:1038 ||| NN
and  ||| S:1038 E:1042 ||| CC
medial  ||| S:1042 E:1049 ||| JJ
gastrocnemius ||| S:1049 E:1062 ||| NN
.  ||| S:1062 E:1064 ||| .
For  ||| S:1064 E:1068 ||| IN
the  ||| S:1068 E:1072 ||| DT
dual-channel  ||| S:1072 E:1085 ||| JJ
FES  ||| S:1085 E:1089 ||| NNP
group ||| S:1089 E:1094 ||| NN
,  ||| S:1094 E:1096 ||| ,
the  ||| S:1096 E:1100 ||| DT
stimulations  ||| S:1100 E:1113 ||| NN
of  ||| S:1113 E:1116 ||| IN
tibialis  ||| S:1116 E:1125 ||| JJ
anterior ||| S:1125 E:1133 ||| NN
,  ||| S:1133 E:1135 ||| ,
peroneus  ||| S:1135 E:1144 ||| JJ
longus  ||| S:1144 E:1151 ||| NN
and  ||| S:1151 E:1155 ||| CC
peroneus  ||| S:1155 E:1164 ||| JJ
brevis  ||| S:1164 E:1171 ||| JJ
muscles  ||| S:1171 E:1179 ||| NNS
were  ||| S:1179 E:1184 ||| VBD
applied ||| S:1184 E:1191 ||| VBN
.  ||| S:1191 E:1193 ||| .
In  ||| S:1193 E:1196 ||| IN
comfort  ||| S:1196 E:1204 ||| NN
electrical  ||| S:1204 E:1215 ||| JJ
stimulation  ||| S:1215 E:1227 ||| NN
group ||| S:1227 E:1232 ||| NN
,  ||| S:1232 E:1234 ||| ,
the  ||| S:1234 E:1238 ||| DT
electrode  ||| S:1238 E:1248 ||| JJ
positions  ||| S:1248 E:1258 ||| NNS
were  ||| S:1258 E:1263 ||| VBD
identical  ||| S:1263 E:1273 ||| JJ
to  ||| S:1273 E:1276 ||| TO
the  ||| S:1276 E:1280 ||| DT
stimulation  ||| S:1280 E:1292 ||| JJ
group ||| S:1292 E:1297 ||| NN
,  ||| S:1297 E:1299 ||| ,
but  ||| S:1299 E:1303 ||| CC
there  ||| S:1303 E:1309 ||| EX
was  ||| S:1309 E:1313 ||| VBD
no  ||| S:1313 E:1316 ||| DT
current  ||| S:1316 E:1324 ||| JJ
output  ||| S:1324 E:1331 ||| NN
during  ||| S:1331 E:1338 ||| IN
stimulation ||| S:1338 E:1349 ||| NN
.  ||| S:1349 E:1351 ||| .
Before  ||| S:1351 E:1358 ||| RB
and  ||| S:1358 E:1362 ||| CC
after  ||| S:1362 E:1368 ||| IN
3-week  ||| S:1368 E:1375 ||| CD
treatment ||| S:1375 E:1384 ||| NN
,  ||| S:1384 E:1386 ||| ,
three  ||| S:1386 E:1392 ||| CD
groups  ||| S:1392 E:1399 ||| NNS
received  ||| S:1399 E:1408 ||| VBD
weekly  ||| S:1408 E:1415 ||| JJ
rehabilitation  ||| S:1415 E:1430 ||| NN
evaluations  ||| S:1430 E:1442 ||| NNS
of  ||| S:1442 E:1445 ||| IN
Fugl-Meyer  ||| S:1445 E:1456 ||| JJ
assessment  ||| S:1456 E:1467 ||| NN
( ||| S:1467 E:1468 ||| -LRB-
FMA ||| S:1468 E:1471 ||| NNP
) ||| S:1471 E:1472 ||| -RRB-
,  ||| S:1472 E:1474 ||| ,
posture  ||| S:1474 E:1482 ||| NN
assessment  ||| S:1482 E:1493 ||| NN
of  ||| S:1493 E:1496 ||| IN
stroke  ||| S:1496 E:1503 ||| JJ
scale  ||| S:1503 E:1509 ||| NN
( ||| S:1509 E:1510 ||| -LRB-
PASS ||| S:1510 E:1514 ||| NNP
) ||| S:1514 E:1515 ||| -RRB-
,  ||| S:1515 E:1517 ||| ,
Brunel  ||| S:1517 E:1524 ||| NNP
balance  ||| S:1524 E:1532 ||| NN
assessment  ||| S:1532 E:1543 ||| NN
( ||| S:1543 E:1544 ||| -LRB-
BBA ||| S:1544 E:1547 ||| NNP
) ||| S:1547 E:1548 ||| -RRB-
,  ||| S:1548 E:1550 ||| ,
Berg  ||| S:1550 E:1555 ||| NNP
balance  ||| S:1555 E:1563 ||| NN
scale  ||| S:1563 E:1569 ||| NN
( ||| S:1569 E:1570 ||| -LRB-
BBS ||| S:1570 E:1573 ||| NNP
)  ||| S:1573 E:1575 ||| -RRB-
and  ||| S:1575 E:1579 ||| CC
modified  ||| S:1579 E:1588 ||| VBN
Barthel  ||| S:1588 E:1596 ||| JJ
index  ||| S:1596 E:1602 ||| NN
( ||| S:1602 E:1603 ||| -LRB-
MBI ||| S:1603 E:1606 ||| NNP
) ||| S:1606 E:1607 ||| -RRB-
.  ||| S:1607 E:1609 ||| .
Before  ||| S:1609 E:1616 ||| RB
and  ||| S:1616 E:1620 ||| CC
after  ||| S:1620 E:1626 ||| IN
treatment ||| S:1626 E:1635 ||| NN
,  ||| S:1635 E:1637 ||| ,
DTI  ||| S:1637 E:1641 ||| NNP
examination  ||| S:1641 E:1653 ||| NN
was  ||| S:1653 E:1657 ||| VBD
performed  ||| S:1657 E:1667 ||| VBN
for  ||| S:1667 E:1671 ||| IN
some  ||| S:1671 E:1676 ||| DT
patients ||| S:1676 E:1684 ||| NNS
.  ||| S:1684 E:1686 ||| .
Among  ||| S:1686 E:1692 ||| IN
three  ||| S:1692 E:1698 ||| CD
groups ||| S:1698 E:1704 ||| NNS
,  ||| S:1704 E:1706 ||| ,
general  ||| S:1706 E:1714 ||| JJ
patient  ||| S:1714 E:1722 ||| NN
profiles  ||| S:1722 E:1731 ||| NNS
and  ||| S:1731 E:1735 ||| CC
pre-treatment  ||| S:1735 E:1749 ||| JJ
evaluations  ||| S:1749 E:1761 ||| NNS
showed  ||| S:1761 E:1768 ||| VBD
no  ||| S:1768 E:1771 ||| DT
significant  ||| S:1771 E:1783 ||| JJ
difference ||| S:1783 E:1793 ||| NN
.  ||| S:1793 E:1795 ||| .
For  ||| S:1795 E:1799 ||| IN
intra-group  ||| S:1799 E:1811 ||| JJ
comparisons  ||| S:1811 E:1823 ||| NNS
versus  ||| S:1823 E:1830 ||| CC
pre-treatment ||| S:1830 E:1843 ||| JJ
,  ||| S:1843 E:1845 ||| ,
at  ||| S:1845 E:1848 ||| IN
week  ||| S:1848 E:1853 ||| NN
1 ||| S:1853 E:1854 ||| CD
,  ||| S:1854 E:1856 ||| ,
2  ||| S:1856 E:1858 ||| CD
and  ||| S:1858 E:1862 ||| CC
3 ||| S:1862 E:1863 ||| CD
,  ||| S:1863 E:1865 ||| ,
the  ||| S:1865 E:1869 ||| DT
scores  ||| S:1869 E:1876 ||| NNS
of  ||| S:1876 E:1879 ||| IN
PASS ||| S:1879 E:1883 ||| NNP
,  ||| S:1883 E:1885 ||| ,
BBA ||| S:1885 E:1888 ||| NNP
,  ||| S:1888 E:1890 ||| ,
BBS ||| S:1890 E:1893 ||| NNP
,  ||| S:1893 E:1895 ||| ,
FMA  ||| S:1895 E:1899 ||| NNP
and  ||| S:1899 E:1903 ||| CC
MBI  ||| S:1903 E:1907 ||| NNP
had  ||| S:1907 E:1911 ||| VBD
statistically  ||| S:1911 E:1925 ||| RB
significant  ||| S:1925 E:1937 ||| JJ
differences  ||| S:1937 E:1949 ||| NNS
( ||| S:1949 E:1950 ||| -LRB-
P  ||| S:1950 E:1952 ||| NNP
< ||| S:1952 E:1954 ||| SYM
0.05 ||| S:1954 E:1958 ||| CD
) ||| S:1958 E:1959 ||| -RRB-
;  ||| S:1959 E:1961 ||| :
At  ||| S:1961 E:1964 ||| IN
week  ||| S:1964 E:1969 ||| NN
3  ||| S:1969 E:1971 ||| CD
post-treatment ||| S:1971 E:1985 ||| NN
,  ||| S:1985 E:1987 ||| ,
when  ||| S:1987 E:1992 ||| WRB
four-channel  ||| S:1992 E:2005 ||| JJ
and  ||| S:2005 E:2009 ||| CC
double-channel  ||| S:2009 E:2024 ||| NNP
FES  ||| S:2024 E:2028 ||| NNP
groups  ||| S:2028 E:2035 ||| NNS
were  ||| S:2035 E:2040 ||| VBD
compared  ||| S:2040 E:2049 ||| VBN
versus  ||| S:2049 E:2056 ||| IN
pre-treatment ||| S:2056 E:2069 ||| NNP
,  ||| S:2069 E:2071 ||| ,
the  ||| S:2071 E:2075 ||| DT
scores  ||| S:2075 E:2082 ||| NNS
of  ||| S:2082 E:2085 ||| IN
ipsilateral  ||| S:2085 E:2097 ||| JJ
FA  ||| S:2097 E:2100 ||| NNP
had  ||| S:2100 E:2104 ||| VBD
statistically  ||| S:2104 E:2118 ||| RB
significant  ||| S:2118 E:2130 ||| JJ
differences  ||| S:2130 E:2142 ||| NNS
( ||| S:2142 E:2143 ||| -LRB-
P  ||| S:2143 E:2145 ||| NNP
< ||| S:2145 E:2147 ||| SYM
0.05 ||| S:2147 E:2151 ||| CD
) ||| S:2151 E:2152 ||| -RRB-
.  ||| S:2152 E:2154 ||| .
At  ||| S:2154 E:2157 ||| IN
week  ||| S:2157 E:2162 ||| NN
1  ||| S:2162 E:2164 ||| CD
post-treatment ||| S:2164 E:2178 ||| NN
,  ||| S:2178 E:2180 ||| ,
MBI  ||| S:2180 E:2184 ||| NNP
had  ||| S:2184 E:2188 ||| VBD
statistically  ||| S:2188 E:2202 ||| RB
significant  ||| S:2202 E:2214 ||| JJ
difference  ||| S:2214 E:2225 ||| NN
among  ||| S:2225 E:2231 ||| IN
3  ||| S:2231 E:2233 ||| CD
groups  ||| S:2233 E:2240 ||| NNS
( ||| S:2240 E:2241 ||| -LRB-
P  ||| S:2241 E:2243 ||| NN
=  ||| S:2243 E:2245 ||| SYM
0.037 ||| S:2245 E:2250 ||| CD
) ||| S:2250 E:2251 ||| -RRB-
.  ||| S:2251 E:2253 ||| .
As  ||| S:2253 E:2256 ||| RB
compared  ||| S:2256 E:2265 ||| VBN
with  ||| S:2265 E:2270 ||| IN
placebo ||| S:2270 E:2277 ||| NN
,  ||| S:2277 E:2279 ||| ,
four-channel  ||| S:2279 E:2292 ||| JJ
group  ||| S:2292 E:2298 ||| NN
had  ||| S:2298 E:2302 ||| VBD
statistically  ||| S:2302 E:2316 ||| RB
significant  ||| S:2316 E:2328 ||| JJ
difference  ||| S:2328 E:2339 ||| NN
[ ||| S:2339 E:2340 ||| -LRB-
( ||| S:2340 E:2341 ||| -LRB-
52  ||| S:2341 E:2344 ||| CD
±  ||| S:2344 E:2346 ||| CD
12 ||| S:2346 E:2348 ||| CD
)  ||| S:2348 E:2350 ||| -RRB-
vs  ||| S:2350 E:2353 ||| NNS
( ||| S:2353 E:2354 ||| -LRB-
38  ||| S:2354 E:2357 ||| CD
±  ||| S:2357 E:2359 ||| CD
18 ||| S:2359 E:2361 ||| CD
) ||| S:2361 E:2362 ||| -RRB-
,  ||| S:2362 E:2364 ||| ,
P  ||| S:2364 E:2366 ||| NN
< ||| S:2366 E:2368 ||| SYM
0.05 ||| S:2368 E:2372 ||| CD
] ||| S:2372 E:2373 ||| -RRB-
;  ||| S:2373 E:2375 ||| :
At  ||| S:2375 E:2378 ||| IN
week  ||| S:2378 E:2383 ||| NN
2  ||| S:2383 E:2385 ||| CD
post-treatment ||| S:2385 E:2399 ||| NN
,  ||| S:2399 E:2401 ||| ,
the  ||| S:2401 E:2405 ||| DT
scores  ||| S:2405 E:2412 ||| NNS
of  ||| S:2412 E:2415 ||| IN
PASS  ||| S:2415 E:2420 ||| NNP
and  ||| S:2420 E:2424 ||| CC
MBI  ||| S:2424 E:2428 ||| NNP
were  ||| S:2428 E:2433 ||| VBD
( ||| S:2433 E:2434 ||| -LRB-
29  ||| S:2434 E:2437 ||| CD
±  ||| S:2437 E:2439 ||| CD
3 ||| S:2439 E:2440 ||| CD
,  ||| S:2440 E:2442 ||| ,
73  ||| S:2442 E:2445 ||| CD
±  ||| S:2445 E:2447 ||| CD
13 ||| S:2447 E:2449 ||| CD
)  ||| S:2449 E:2451 ||| -RRB-
in  ||| S:2451 E:2454 ||| IN
four-channel  ||| S:2454 E:2467 ||| NNP
FES  ||| S:2467 E:2471 ||| NNP
group  ||| S:2471 E:2477 ||| NN
versus  ||| S:2477 E:2484 ||| FW
( ||| S:2484 E:2485 ||| -LRB-
24  ||| S:2485 E:2488 ||| CD
±  ||| S:2488 E:2490 ||| CD
8 ||| S:2490 E:2491 ||| CD
,  ||| S:2491 E:2493 ||| ,
60  ||| S:2493 E:2496 ||| CD
±  ||| S:2496 E:2498 ||| CD
17 ||| S:2498 E:2500 ||| CD
)  ||| S:2500 E:2502 ||| -RRB-
in  ||| S:2502 E:2505 ||| IN
dual-channel  ||| S:2505 E:2518 ||| NNP
FES  ||| S:2518 E:2522 ||| NNP
group ||| S:2522 E:2527 ||| NN
.  ||| S:2527 E:2529 ||| .
And  ||| S:2529 E:2533 ||| CC
the  ||| S:2533 E:2537 ||| DT
scores  ||| S:2537 E:2544 ||| NNS
of  ||| S:2544 E:2547 ||| IN
PASS ||| S:2547 E:2551 ||| NNP
,  ||| S:2551 E:2553 ||| ,
BBA ||| S:2553 E:2556 ||| NNP
,  ||| S:2556 E:2558 ||| ,
BBS ||| S:2558 E:2561 ||| NNP
,  ||| S:2561 E:2563 ||| ,
FMA  ||| S:2563 E:2567 ||| NNP
and  ||| S:2567 E:2571 ||| CC
MBI  ||| S:2571 E:2575 ||| NNP
were  ||| S:2575 E:2580 ||| VBD
( ||| S:2580 E:2581 ||| -LRB-
9  ||| S:2581 E:2583 ||| CD
±  ||| S:2583 E:2585 ||| CD
3 ||| S:2585 E:2586 ||| CD
,  ||| S:2586 E:2588 ||| ,
8.3  ||| S:2588 E:2592 ||| CD
±  ||| S:2592 E:2594 ||| CD
2.4 ||| S:2594 E:2597 ||| CD
,  ||| S:2597 E:2599 ||| ,
37  ||| S:2599 E:2602 ||| CD
±  ||| S:2602 E:2604 ||| CD
7 ||| S:2604 E:2605 ||| CD
,  ||| S:2605 E:2607 ||| ,
22  ||| S:2607 E:2610 ||| CD
±  ||| S:2610 E:2612 ||| CD
5 ||| S:2612 E:2613 ||| CD
,  ||| S:2613 E:2615 ||| ,
73  ||| S:2615 E:2618 ||| CD
±  ||| S:2618 E:2620 ||| CD
13 ||| S:2620 E:2622 ||| CD
)  ||| S:2622 E:2624 ||| -RRB-
in  ||| S:2624 E:2627 ||| IN
four-channel  ||| S:2627 E:2640 ||| NNP
FES  ||| S:2640 E:2644 ||| NNP
group  ||| S:2644 E:2650 ||| NN
versus  ||| S:2650 E:2657 ||| FW
( ||| S:2657 E:2658 ||| -LRB-
21  ||| S:2658 E:2661 ||| CD
±  ||| S:2661 E:2663 ||| CD
7 ||| S:2663 E:2664 ||| CD
,  ||| S:2664 E:2666 ||| ,
6.2  ||| S:2666 E:2670 ||| CD
±  ||| S:2670 E:2672 ||| CD
3.1 ||| S:2672 E:2675 ||| CD
,  ||| S:2675 E:2677 ||| ,
24  ||| S:2677 E:2680 ||| CD
±  ||| S:2680 E:2682 ||| CD
16 ||| S:2682 E:2684 ||| CD
,  ||| S:2684 E:2686 ||| ,
15  ||| S:2686 E:2689 ||| CD
±  ||| S:2689 E:2691 ||| CD
8 ||| S:2691 E:2692 ||| CD
,  ||| S:2692 E:2694 ||| ,
47  ||| S:2694 E:2697 ||| CD
±  ||| S:2697 E:2699 ||| CD
20 ||| S:2699 E:2701 ||| CD
)  ||| S:2701 E:2703 ||| -RRB-
in  ||| S:2703 E:2706 ||| IN
comfort  ||| S:2706 E:2714 ||| NN
electrical  ||| S:2714 E:2725 ||| JJ
stimulation  ||| S:2725 E:2737 ||| NN
group ||| S:2737 E:2742 ||| NN
.  ||| S:2742 E:2744 ||| .
When  ||| S:2744 E:2749 ||| WRB
dual-channel  ||| S:2749 E:2762 ||| NNP
FES  ||| S:2762 E:2766 ||| NNP
and  ||| S:2766 E:2770 ||| CC
comfort  ||| S:2770 E:2778 ||| NN
stimulation  ||| S:2778 E:2790 ||| NN
groups  ||| S:2790 E:2797 ||| NNS
were  ||| S:2797 E:2802 ||| VBD
compared ||| S:2802 E:2810 ||| VBN
,  ||| S:2810 E:2812 ||| ,
MBI  ||| S:2812 E:2816 ||| NNP
had  ||| S:2816 E:2820 ||| VBD
significant  ||| S:2820 E:2832 ||| JJ
statistical  ||| S:2832 E:2844 ||| JJ
difference  ||| S:2844 E:2855 ||| NN
[ ||| S:2855 E:2856 ||| -LRB-
( ||| S:2856 E:2857 ||| -LRB-
60  ||| S:2857 E:2860 ||| CD
±  ||| S:2860 E:2862 ||| CD
17 ||| S:2862 E:2864 ||| CD
)  ||| S:2864 E:2866 ||| -RRB-
vs  ||| S:2866 E:2869 ||| NNS
( ||| S:2869 E:2870 ||| -LRB-
47  ||| S:2870 E:2873 ||| CD
±  ||| S:2873 E:2875 ||| CD
20 ||| S:2875 E:2877 ||| CD
) ||| S:2877 E:2878 ||| -RRB-
,  ||| S:2878 E:2880 ||| ,
P  ||| S:2880 E:2882 ||| NN
< ||| S:2882 E:2884 ||| SYM
0.05 ||| S:2884 E:2888 ||| CD
] ||| S:2888 E:2889 ||| -RRB-
.  ||| S:2889 E:2891 ||| .
At  ||| S:2891 E:2894 ||| IN
week  ||| S:2894 E:2899 ||| NN
3  ||| S:2899 E:2901 ||| CD
post-treatment ||| S:2901 E:2915 ||| NN
,  ||| S:2915 E:2917 ||| ,
four-channel  ||| S:2917 E:2930 ||| JJ
and  ||| S:2930 E:2934 ||| CC
dual-channel  ||| S:2934 E:2947 ||| NNP
FES  ||| S:2947 E:2951 ||| NNP
groups  ||| S:2951 E:2958 ||| NNS
were  ||| S:2958 E:2963 ||| VBD
compared ||| S:2963 E:2971 ||| VBN
,  ||| S:2971 E:2973 ||| ,
there  ||| S:2973 E:2979 ||| EX
was  ||| S:2979 E:2983 ||| VBD
also  ||| S:2983 E:2988 ||| RB
statistical  ||| S:2988 E:3000 ||| JJ
significance  ||| S:3000 E:3013 ||| NN
in  ||| S:3013 E:3016 ||| IN
FMA  ||| S:3016 E:3020 ||| NNP
[ ||| S:3020 E:3021 ||| -LRB-
( ||| S:3021 E:3022 ||| -LRB-
25  ||| S:3022 E:3025 ||| CD
±  ||| S:3025 E:3027 ||| CD
5 ||| S:3027 E:3028 ||| CD
)  ||| S:3028 E:3030 ||| -RRB-
vs  ||| S:3030 E:3033 ||| NNS
( ||| S:3033 E:3034 ||| -LRB-
20  ||| S:3034 E:3037 ||| CD
±  ||| S:3037 E:3039 ||| CD
7 ||| S:3039 E:3040 ||| CD
) ||| S:3040 E:3041 ||| -RRB-
,  ||| S:3041 E:3043 ||| ,
P  ||| S:3043 E:3045 ||| NN
=  ||| S:3045 E:3047 ||| SYM
0.055 ||| S:3047 E:3052 ||| CD
] ||| S:3052 E:3053 ||| -RRB-
.  ||| S:3053 E:3055 ||| .
The  ||| S:3055 E:3059 ||| DT
scores  ||| S:3059 E:3066 ||| NNS
of  ||| S:3066 E:3069 ||| IN
PASS ||| S:3069 E:3073 ||| NNP
,  ||| S:3073 E:3075 ||| ,
BBS ||| S:3075 E:3078 ||| NNP
,  ||| S:3078 E:3080 ||| ,
FMA  ||| S:3080 E:3084 ||| NNP
and  ||| S:3084 E:3088 ||| CC
MBI  ||| S:3088 E:3092 ||| NNP
were  ||| S:3092 E:3097 ||| VBD
( ||| S:3097 E:3098 ||| -LRB-
31  ||| S:3098 E:3101 ||| CD
±  ||| S:3101 E:3103 ||| CD
3 ||| S:3103 E:3104 ||| CD
,  ||| S:3104 E:3106 ||| ,
43  ||| S:3106 E:3109 ||| CD
±  ||| S:3109 E:3111 ||| CD
8 ||| S:3111 E:3112 ||| CD
,  ||| S:3112 E:3114 ||| ,
25  ||| S:3114 E:3117 ||| CD
±  ||| S:3117 E:3119 ||| CD
5 ||| S:3119 E:3120 ||| CD
,  ||| S:3120 E:3122 ||| ,
81  ||| S:3122 E:3125 ||| CD
±  ||| S:3125 E:3127 ||| CD
13 ||| S:3127 E:3129 ||| CD
)  ||| S:3129 E:3131 ||| -RRB-
in  ||| S:3131 E:3134 ||| IN
four-channel  ||| S:3134 E:3147 ||| NNP
FES  ||| S:3147 E:3151 ||| NNP
group  ||| S:3151 E:3157 ||| NN
versus  ||| S:3157 E:3164 ||| FW
( ||| S:3164 E:3165 ||| -LRB-
25  ||| S:3165 E:3168 ||| CD
±  ||| S:3168 E:3170 ||| CD
8 ||| S:3170 E:3171 ||| CD
,  ||| S:3171 E:3173 ||| ,
29  ||| S:3173 E:3176 ||| CD
±  ||| S:3176 E:3178 ||| CD
17 ||| S:3178 E:3180 ||| CD
,  ||| S:3180 E:3182 ||| ,
17  ||| S:3182 E:3185 ||| CD
±  ||| S:3185 E:3187 ||| CD
9 ||| S:3187 E:3188 ||| CD
,  ||| S:3188 E:3190 ||| ,
54  ||| S:3190 E:3193 ||| CD
±  ||| S:3193 E:3195 ||| CD
25 ||| S:3195 E:3197 ||| CD
)  ||| S:3197 E:3199 ||| -RRB-
in  ||| S:3199 E:3202 ||| IN
comfort  ||| S:3202 E:3210 ||| NN
stimulation  ||| S:3210 E:3222 ||| NN
group  ||| S:3222 E:3228 ||| NN
respectively ||| S:3228 E:3240 ||| RB
.  ||| S:3240 E:3242 ||| .
When  ||| S:3242 E:3247 ||| WRB
dual-channel  ||| S:3247 E:3260 ||| NNP
FES  ||| S:3260 E:3264 ||| NNP
and  ||| S:3264 E:3268 ||| CC
comfort  ||| S:3268 E:3276 ||| NN
stimulation  ||| S:3276 E:3288 ||| NN
groups  ||| S:3288 E:3295 ||| NNS
were  ||| S:3295 E:3300 ||| VBD
compared ||| S:3300 E:3308 ||| VBN
,  ||| S:3308 E:3310 ||| ,
the  ||| S:3310 E:3314 ||| DT
scores  ||| S:3314 E:3321 ||| NNS
of  ||| S:3321 E:3324 ||| IN
MBI  ||| S:3324 E:3328 ||| NNP
were  ||| S:3328 E:3333 ||| VBD
( ||| S:3333 E:3334 ||| -LRB-
71  ||| S:3334 E:3337 ||| CD
±  ||| S:3337 E:3339 ||| CD
15 ||| S:3339 E:3341 ||| CD
)  ||| S:3341 E:3343 ||| -RRB-
and  ||| S:3343 E:3347 ||| CC
( ||| S:3347 E:3348 ||| -LRB-
54  ||| S:3348 E:3351 ||| CD
±  ||| S:3351 E:3353 ||| CD
25 ||| S:3353 E:3355 ||| CD
)  ||| S:3355 E:3357 ||| -RRB-
respectively ||| S:3357 E:3369 ||| RB
.  ||| S:3369 E:3371 ||| .
And  ||| S:3371 E:3375 ||| CC
the  ||| S:3375 E:3379 ||| DT
difference  ||| S:3379 E:3390 ||| NN
was  ||| S:3390 E:3394 ||| VBD
statistically  ||| S:3394 E:3408 ||| RB
significant  ||| S:3408 E:3420 ||| JJ
( ||| S:3420 E:3421 ||| -LRB-
P  ||| S:3421 E:3423 ||| NNP
< ||| S:3423 E:3425 ||| SYM
0.05 ||| S:3425 E:3429 ||| CD
) ||| S:3429 E:3430 ||| -RRB-
.  ||| S:3430 E:3432 ||| .
At  ||| S:3432 E:3435 ||| IN
week  ||| S:3435 E:3440 ||| NN
3  ||| S:3440 E:3442 ||| CD
post-treatment ||| S:3442 E:3456 ||| NN
,  ||| S:3456 E:3458 ||| ,
the  ||| S:3458 E:3462 ||| DT
scores  ||| S:3462 E:3469 ||| NNS
of  ||| S:3469 E:3472 ||| IN
FA  ||| S:3472 E:3475 ||| NNP
significantly  ||| S:3475 E:3489 ||| RB
increased  ||| S:3489 E:3499 ||| VBN
[ ||| S:3499 E:3500 ||| -LRB-
four-channel  ||| S:3500 E:3513 ||| NNP
FES  ||| S:3513 E:3517 ||| NNP
group  ||| S:3517 E:3523 ||| NN
( ||| S:3523 E:3524 ||| -LRB-
0.321  ||| S:3524 E:3530 ||| CD
±  ||| S:3530 E:3532 ||| CD
0.172 ||| S:3532 E:3537 ||| CD
)  ||| S:3537 E:3539 ||| -RRB-
vs  ||| S:3539 E:3542 ||| JJ
comfort  ||| S:3542 E:3550 ||| NN
stimulation  ||| S:3550 E:3562 ||| NN
group  ||| S:3562 E:3568 ||| NN
( ||| S:3568 E:3569 ||| -LRB-
0.217  ||| S:3569 E:3575 ||| CD
±  ||| S:3575 E:3577 ||| CD
0.135 ||| S:3577 E:3582 ||| CD
)  ||| S:3582 E:3584 ||| -RRB-
( ||| S:3584 E:3585 ||| -LRB-
P  ||| S:3585 E:3587 ||| NN
=  ||| S:3587 E:3589 ||| SYM
0.020 ||| S:3589 E:3594 ||| CD
) ||| S:3594 E:3595 ||| -RRB-
] ||| S:3595 E:3596 ||| -RRB-
.  ||| S:3596 E:3598 ||| .
When  ||| S:3598 E:3603 ||| WRB
dual-channel  ||| S:3603 E:3616 ||| NNP
FES  ||| S:3616 E:3620 ||| NNP
group  ||| S:3620 E:3626 ||| NN
( ||| S:3626 E:3627 ||| -LRB-
0.333  ||| S:3627 E:3633 ||| CD
±  ||| S:3633 E:3635 ||| CD
0.164 ||| S:3635 E:3640 ||| CD
)  ||| S:3640 E:3642 ||| -RRB-
and  ||| S:3642 E:3646 ||| CC
comfort  ||| S:3646 E:3654 ||| NN
stimulation  ||| S:3654 E:3666 ||| NN
group  ||| S:3666 E:3672 ||| NN
( ||| S:3672 E:3673 ||| -LRB-
0.217  ||| S:3673 E:3679 ||| CD
±  ||| S:3679 E:3681 ||| CD
0.135 ||| S:3681 E:3686 ||| CD
)  ||| S:3686 E:3688 ||| -RRB-
( ||| S:3688 E:3689 ||| -LRB-
P  ||| S:3689 E:3691 ||| NN
=  ||| S:3691 E:3693 ||| SYM
0.049 ||| S:3693 E:3698 ||| CD
)  ||| S:3698 E:3700 ||| -RRB-
were  ||| S:3700 E:3705 ||| VBD
compared ||| S:3705 E:3713 ||| VBN
,  ||| S:3713 E:3715 ||| ,
the  ||| S:3715 E:3719 ||| DT
differences  ||| S:3719 E:3731 ||| NNS
were  ||| S:3731 E:3736 ||| VBD
statistically  ||| S:3736 E:3750 ||| RB
significant ||| S:3750 E:3761 ||| JJ
.  ||| S:3761 E:3763 ||| .
DTI  ||| S:3763 E:3767 ||| NNP
showed  ||| S:3767 E:3774 ||| VBD
that  ||| S:3774 E:3779 ||| IN
four-channel  ||| S:3779 E:3792 ||| NNP
FES  ||| S:3792 E:3796 ||| NNP
group  ||| S:3796 E:3802 ||| NN
increased  ||| S:3802 E:3812 ||| VBD
significantly ||| S:3812 E:3825 ||| RB
,  ||| S:3825 E:3827 ||| ,
but  ||| S:3827 E:3831 ||| CC
contralateral  ||| S:3831 E:3845 ||| JJ
fiber  ||| S:3845 E:3851 ||| NN
bundle  ||| S:3851 E:3858 ||| NN
was  ||| S:3858 E:3862 ||| VBD
not  ||| S:3862 E:3866 ||| RB
obvious ||| S:3866 E:3873 ||| JJ
.  ||| S:3873 E:3875 ||| .
And  ||| S:3875 E:3879 ||| CC
the  ||| S:3879 E:3883 ||| DT
improvements  ||| S:3883 E:3896 ||| NNS
of  ||| S:3896 E:3899 ||| IN
dual-channel  ||| S:3899 E:3912 ||| NNP
FES  ||| S:3912 E:3916 ||| NNP
and  ||| S:3916 E:3920 ||| CC
comfort  ||| S:3920 E:3928 ||| NN
stimulation  ||| S:3928 E:3940 ||| NN
groups  ||| S:3940 E:3947 ||| NNS
were  ||| S:3947 E:3952 ||| VBD
insignificant ||| S:3952 E:3965 ||| JJ
.  ||| S:3965 E:3967 ||| .
Compared  ||| S:3967 E:3976 ||| VBN
with  ||| S:3976 E:3981 ||| IN
traditional  ||| S:3981 E:3993 ||| JJ
dual-channel  ||| S:3993 E:4006 ||| JJ
FES ||| S:4006 E:4009 ||| NNP
,  ||| S:4009 E:4011 ||| ,
functional  ||| S:4011 E:4022 ||| JJ
electrical  ||| S:4022 E:4033 ||| JJ
stimulation  ||| S:4033 E:4045 ||| NN
based  ||| S:4045 E:4051 ||| VBN
on  ||| S:4051 E:4054 ||| IN
human  ||| S:4054 E:4060 ||| JJ
walking  ||| S:4060 E:4068 ||| NN
patterns  ||| S:4068 E:4077 ||| NNS
is  ||| S:4077 E:4080 ||| VBZ
more  ||| S:4080 E:4085 ||| JJR
efficacious ||| S:4085 E:4096 ||| NN
.  ||| S:4096 E:4098 ||| .
And  ||| S:4098 E:4102 ||| CC
it  ||| S:4102 E:4105 ||| PRP
helps  ||| S:4105 E:4111 ||| VBZ
to  ||| S:4111 E:4114 ||| TO
restore  ||| S:4114 E:4122 ||| VB
brain  ||| S:4122 E:4128 ||| NN
structure  ||| S:4128 E:4138 ||| NN
and  ||| S:4138 E:4142 ||| CC
function  ||| S:4142 E:4151 ||| NN
and  ||| S:4151 E:4155 ||| CC
promote  ||| S:4155 E:4163 ||| VB
motor  ||| S:4163 E:4169 ||| NN
function  ||| S:4169 E:4178 ||| NN
recovery  ||| S:4178 E:4187 ||| NN
in  ||| S:4187 E:4190 ||| IN
patients  ||| S:4190 E:4199 ||| NNS
with  ||| S:4199 E:4204 ||| IN
early  ||| S:4204 E:4210 ||| JJ
stroke ||| S:4210 E:4216 ||| NN
.  ||| S:4216 E:4218 ||| .
